6721 - 6730 of 7915 Results
Title
Year
-
OPENTitle: Structural Characterization of LRRK2 InhibitorsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 58Issue #: 9Start Page: 3751End Page: 3756Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm5018779Best OA location URL: https://pure.rug.nl/ws/files/85554165/Structural_Characterization_of_LRRK2_Inhibitors.pdfCitation Count: 37
-
OPENTitle: Classification of pallidal oscillations with increasing parkinsonian severityJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 114Issue #: 1Start Page: 209End Page: 218Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00840.2014Best OA location URL: https://europepmc.org/articles/pmc4507953Citation Count: 21
-
RESTRICTEDTitle: LRRK2 mutations and neurotoxicant susceptibilityJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 240Issue #: 6Start Page: 752End Page: 759Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1535370215579162Best OA location URL: https://europepmc.org/articles/pmc4935210?pdf=renderCitation Count: 28
- Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease2015OPENTitle: Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's diseaseJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 18Issue #: 5Start Page: 779End Page: 786Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.3997Best OA location URL: https://europepmc.org/articles/pmc4414895?pdf=renderCitation Count: 560
-
RESTRICTEDTitle: Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and functionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 78Issue #:Start Page: 100End Page: 114Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.03.008Citation Count: 23
-
OPENTitle: Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteinsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 79Issue #:Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.032Best OA location URL: https://europepmc.org/articles/pmc4458424?pdf=renderCitation Count: 37
-
RESTRICTEDTitle: Minimal change multiple system atrophy: An aggressive variant?Journal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 960End Page: 967Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26220Citation Count: 48
-
OPENTitle: Onset of Mild Cognitive Impairment in Parkinson DiseaseJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 30Issue #: 2Start Page: 127End Page: 133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0000000000000088Best OA location URL: https://epublications.marquette.edu/cgi/viewcontent.cgi?article=1530&context=nursing_facCitation Count: 28
-
OPENTitle: Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 InhibitorJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 6Issue #: 5Start Page: 584End Page: 589Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.5b00064Best OA location URL: https://europepmc.org/articles/pmc4434483?pdf=renderCitation Count: 48
- Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials2015RESTRICTEDTitle: Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trialsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 14Start Page: 1488End Page: 1494Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001451Best OA location URL: https://europepmc.org/articles/pmc4395889?pdf=renderCitation Count: 49